April 26 Stock Analyst Downgrades (BVNRY, BYPLF, CAIXY, CCAP, CDAK, CDXC, COLL, CRSR, CSTR, CTTAY)


Stock analyst downgrades for Tuesday, April 26:

Bavarian Nordic A/S (OTCMKTS: BVNRY) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and infectious disease vaccines. The Company’s product pipeline includes IMVAMUNE(R), PROSTVAC(R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark. “

Bodycote (OTCMKTS: BYPLF) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “Bodycote PLC provides heat treatment services through heat treatment, metal joining, surface technology and hot isostatic pressing. It serves the aerospace, defense, automotive, power generation, oil and gas, construction, medical and transport. Bodycote PLC is headquartered in Macclesfield, UK.”

CaixaBank (OTCMKTS: CAIXY) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “CaixaBank SA provides banking and financial products. The Company’s segments include Banking and Insurance division which provides financial services to individuals, including retail banking, private and personal banking, professional clients, such as commercial and corporate banking, cash management and market solutions, as well as insurance products. The Investments division includes investments. CaixaBank SA is based in Valencia, Spain. ”

Crescent Capital BDC (NASDAQ:CCAP) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “Crescent Capital BDC Inc. is a business development company. It focuses on origination and investment in middle market private corporate debt. Crescent Capital BDC Inc. is based in California, USA. “

Codiak BioSciences (NASDAQ:CDAK) was downgraded by analysts from Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Codiak BioSciences Inc. is a clinical-stage biopharmaceutical company. He focuses on the development of exosome-based therapies for oncology, neuro-oncology, neurology, neuromuscular diseases and infectious diseases. Codiak BioSciences Inc. is based in CAMBRIDGE, Mass. “

ChromaDex (NASDAQ:CDXC) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “ChromaDex Corporation and its subsidiaries provide phytochemical reference standards and reference materials, related contract services and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. . ChromaDex’s core business strategy is to use the intellectual property leveraged through its expertise in the field of natural products and in the creation of reference materials for industry as the basis for providing its customers with new and alternative, green and marketable products. en masse. The company’s main priority is to create industry accepted information and provide products and services to all segments of the functional food, pharmaceutical, personal care and dietary supplement markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand and in Mexico. “

Collegium Pharmaceutical (NASDAQ: COLL) was downgraded by analysts from Zacks Investment Research from a holding rating to a strong sell rating. According to Zacks, “Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and markets prescription and over-the-counter pharmaceutical products for the treatment of central nervous system, respiratory and skin disorders. The Company’s product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are undergoing different clinical trials. It has developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, USA. “

Corsair Gaming (NASDAQ:CRSR) was downgraded by analysts from Zacks Investment Research from a holding rating to a strong sell rating. According to Zacks, “Corsair Gaming, Inc. designs, markets and distributes gaming and streaming peripherals, components and systems primarily in the United States and internationally. Corsair Gaming, Inc. is based in Fremont, California. “

CapStar Financial (NASDAQ:CSTR) was downgraded by analysts from Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CapStar Financial Holdings, Inc. is a bank holding company. It mainly operates through its wholly owned subsidiary, CapStar Bank. The Company offers banking products and services that include savings accounts, debit and credit cards, personal and business loans, mortgages, lines of credit, wealth management and online banking. CapStar Financial Holdings, Inc. is headquartered in Nashville, Tennessee. “

Continental Aktiengesellschaft (OTCMKTS: CTTAY) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “Continental AG manufactures tires, automotive parts and industrial products. The Company’s operating segment includes the Chassis and Safety segment, which develops and produces systems for the automotive industry; the Powertrain segment, which integrates system solutions for the powertrain and vehicles of all categories; Interior segment, which offers information management solutions to network drivers and passengers with their own and other vehicles, Tires segment, which offers tires for passenger cars, trucks, buses, construction vehicles, vehicles industrial, bicycles and motorcycles and ContiTech segment, which develops rubber and plastic products. Continental AG is headquartered in Hannover, Germany. “

Camping World (NYSE: CWH) was downgraded by analysts from Zacks Investment Research from a hold price to a sell price. According to Zacks, “Camping World Holdings, Inc. is a provider of services, protection plans, products and resources for recreational vehicle enthusiasts. The company’s brand consists of Camping World and Good Sam. It offers new and used RVs for sale, vehicle servicing and maintenance through retail outlets and membership clubs . Camping World Holdings, Inc. is based in Lincolnshire, USA. “

Logistics Partners Delek (NYSE: DKL) was downgraded by analysts from Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Delek Logistics Partners, LP owns, operates, acquires and constructs crude oil and refined products logistics and marketing assets. The Company operates crude oil transmission pipelines, refined products pipelines, crude oil gathering system and associated crude oil storage tanks. It also provides marketing services for refined products other than jet fuel and petroleum coke; and light goods, operates light goods terminals in Texas and Tennessee and provides terminalling services to independent third parties. Delek Logistics Partners, LP is headquartered in Brentwood, Tennessee. “

Digital Ocean (NASDAQ: DOCN) was downgraded by analysts from Zacks Investment Research from a holding rating to a strong sell rating. According to Zacks, “DigitalOcean helps developers, startups, and small-to-medium businesses rapidly build, deploy, and scale applications to accelerate innovation and increase productivity and agility. DigitalOcean is based in New York, USA. -United. “



Get news and reviews for Bavarian Nordic A/S Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Bavarian Nordic A/S and related companies with MarketBeat.com’s free daily email newsletter.

About Wanda Dufresne

Check Also

Karolinska Development’s Portfolio Company Umecrine Cognition Secures Funding Ahead of Phase 2 Study of Golexanolone in Primary Biliary Cholangitis

Karolinska Development AB (publ) STOCKHOLM, SWEDEN – September 14, 2022. Karolinska Development AB (Nasdaq Stockholm: …